← FDA DRUG APPROVALS

FDA NDA · NDA020410

GASTROMARK

Sponsor: AMAG PHARMS INC

APPLICATION
NDA020410
TYPE
NDA
ORIGINAL APPROVAL
1996-12-06
LATEST ACTION
2013-04-05
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Discontinued

Products

GASTROMARKDiscontinued
FERUMOXSIL EQ 0.175MG IRON/ML · SUSPENSION · ORAL

Approval history

2013-04-05Manufacturing (CMC) · Supplement 3 · standardAP
1999-07-30Manufacturing (CMC) · Supplement 1 · standardAP
1996-12-06Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →